| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 131 | 147 | 163 | 150 | 155 | 167 | 230 | 213 | 199 | 198 | 231 | 228 | 641 | 237 | 254 | 273 | 284 | 279 | 290 | 317 | 302 | 297 | 352 | 358 | 363 | 323 | 351 | 362 | 388 | 342 | 339 | 378 | 368 | 334 | 356 | 337 | 365 | 393 | 373 | 397 | 403 |
| Expenses | 130 | 128 | 137 | 144 | 143 | 157 | 208 | 201 | 176 | 178 | 179 | 210 | 213 | 213 | 224 | 235 | 243 | 240 | 247 | 266 | 256 | 250 | 300 | 291 | 319 | 300 | 331 | 322 | 350 | 342 | 335 | 365 | 432 | 365 | 331 | 307 | 334 | 348 | 334 | 357 | 356 |
| EBITDA | 1 | 19 | 26 | 6 | 12 | 10 | 22 | 12 | 22 | 20 | 52 | 19 | 428 | 24 | 30 | 38 | 41 | 40 | 43 | 51 | 47 | 47 | 52 | 67 | 45 | 23 | 20 | 40 | 37 | -0 | 4 | 13 | -63 | -31 | 25 | 30 | 32 | 45 | 39 | 40 | 48 |
| Operating Profit % | 0 % | 12 % | 13 % | 2 % | 6 % | 5 % | 8 % | 3 % | 11 % | 8 % | 10 % | 7 % | 8 % | 10 % | 11 % | 13 % | 14 % | 14 % | 13 % | 16 % | 15 % | 15 % | 14 % | 18 % | 12 % | 6 % | 6 % | 10 % | 9 % | -0 % | 1 % | 3 % | -18 % | -10 % | 4 % | 7 % | 8 % | 11 % | 9 % | 9 % | 11 % |
| Depreciation | 10 | 9 | 9 | 11 | 16 | 13 | 16 | 13 | 10 | 10 | 10 | 12 | 10 | 10 | 10 | 11 | 11 | 12 | 13 | 13 | 13 | 13 | 13 | 12 | 13 | 13 | 13 | 13 | 13 | 14 | 13 | 14 | 15 | 14 | 15 | 16 | 17 | 16 | 17 | 17 | 16 |
| Interest | 11 | 11 | 8 | 8 | 10 | 8 | 9 | 8 | 7 | 6 | 7 | 10 | 10 | 8 | 8 | 8 | 9 | 9 | 8 | 10 | 9 | 8 | 7 | 6 | 3 | 3 | 3 | 4 | 6 | 7 | 8 | 10 | 11 | 11 | 13 | 13 | 12 | 16 | 14 | 15 | 15 |
| Profit Before Tax | -16 | 1 | 8 | -8 | -15 | -11 | -2 | -9 | 6 | 4 | 34 | -3 | 409 | 7 | 12 | 18 | 22 | 19 | 23 | 28 | 24 | 26 | 32 | 50 | 29 | 7 | 4 | 24 | 18 | -21 | -18 | -10 | -89 | -56 | -3 | 2 | 3 | 12 | 8 | 8 | 16 |
| Tax | 3 | 1 | 1 | 1 | 0 | 1 | 2 | 2 | -5 | 2 | 4 | 4 | 4 | 2 | -3 | 3 | 0 | 4 | -2 | 4 | 6 | 7 | 8 | 12 | 6 | 5 | -10 | 5 | 8 | -6 | -13 | -0 | 4 | -21 | 4 | -9 | 1 | 3 | 2 | 2 | 6 |
| Net Profit | -19 | -0 | 7 | -8 | -15 | -12 | -4 | -11 | 11 | 2 | 31 | -7 | 405 | 5 | 16 | 16 | 21 | 15 | 25 | 24 | 18 | 19 | 24 | 38 | 24 | 3 | 14 | 19 | 10 | -15 | -4 | -10 | -92 | -35 | -7 | 11 | 1 | 9 | 6 | 7 | 10 |
| EPS in ₹ | -7.09 | 0.01 | 1.27 | -0.50 | -0.55 | -0.43 | -0.22 | -0.21 | 0.28 | 0.09 | 1.21 | -0.39 | 0.14 | 0.14 | 0.63 | 0.54 | 0.71 | 0.47 | 0.88 | 0.83 | 0.69 | 0.93 | 0.86 | 1.45 | 0.84 | 0.04 | 0.58 | 0.69 | 0.36 | -0.60 | -0.15 | -0.36 | -3.77 | -1.40 | -0.34 | 0.33 | -0.04 | 0.26 | 0.11 | 0.14 | 0.37 |
Sequent Scientific
Sequent Scientific
175.43
+1.71
(0.98%)
Market Cap
4,391.10 Cr
EPS
0.88
PE Ratio
199.83
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
240.70
52 Week Low
117.35
PB Ratio
6.18
Debt to Equity
0.71
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
Sequent Scientific Schedules Shareholder and Creditor Meetings for Composite Amalgamation Scheme
2 hours ago
2 hours agoSequent Scientific Limited has scheduled separate meetings for equity shareholders and unsecured trade creditors on August 30, 2025, to consider and approve a Composite Scheme of Amalgamation. The scheme involves Sequent Scientific Limited and nine other companies including Symed Labs Limited, Vandana Life Sciences Private Limited, and Appcure Labs Private Limited. The equity shareholders meeting is set for 10:00 a.m. IST while the unsecured trade creditors meeting will be held at 11:00 a.m. IST on the same day. Both meetings will be conducted through video conferencing. Remote e-voting will be available from August 26 to August 29, 2025. The meetings are being held pursuant to an order from the National Company Law Tribunal, Hyderabad Bench - II. National Securities Depository Limited will provide the e-voting facility for both meetings.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,702.20 | #1 4,08,414.80 | 35.57 | #1 54,729.00 | 12.06 | #1 10,980 | -18.99 | 55.97 | |
6,584.00 | 1,74,784.51 | 80.22 | 9,712.00 | 0.89 | 2,191 | 23.05 | 40.37 | |
1,572.00 | 1,26,971.67 | 22.93 | 28,409.50 | 7.12 | 5,291 | 9.88 | 70.77 | |
3,622.90 | 1,21,969.00 | 63.65 | 11,539.40 | 6.99 | 1,911 | 19.91 | 72.46 | |
1,287.40 | 1,07,442.68 | #1 18.77 | 33,741.20 | 16.73 | 5,725 | 1.26 | 54.50 | |
2,541.60 | 1,04,899.14 | 61.83 | 12,744.20 | 19.57 | 2,007 | -10.91 | 52.39 | |
980.10 | 98,620.99 | 21.15 | 23,511.00 | 13.82 | 4,615 | -0.19 | 54.96 | |
1,960.50 | 89,535.15 | 27.44 | 22,909.50 | #1 19.94 | 3,306 | #1 112.49 | 53.75 | |
32,895.00 | 69,899.58 | 50.72 | 6,684.70 | 10.80 | 1,414 | 27.83 | 42.22 | |
1,127.00 | 65,456.34 | 18.86 | 31,378.10 | 17.55 | 3,366 | -0.50 | 47.15 |
Forecast
Actual
Growth Rate
Revenue Growth
-3.26 %
Net Income Growth
-75.74 %
Cash Flow Change
172.42 %
ROE
-74.51 %
ROCE
-93.16 %
EBITDA Margin (Avg.)
306.20 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 908 | 1,528 | 1,905 | 1,343 | 1,388 | 1,463 | 1,393 | 1,451 | 1,529 | 1,540 | 1,602 |
| Fixed Assets | 474 | 587 | 684 | 476 | 498 | 577 | 536 | 564 | 605 | 592 | 586 |
| Current Assets | 310 | 491 | 728 | 538 | 600 | 704 | 714 | 783 | 780 | 811 | 873 |
| Capital Work in Progress | 39 | 24 | 33 | 18 | 23 | 13 | 31 | 12 | 55 | 16 | 16 |
| Investments | 1 | 428 | 428 | 239 | 180 | 172 | 83 | 38 | 0 | 4 | 0 |
| Other Assets | 394 | 491 | 760 | 610 | 687 | 701 | 744 | 837 | 869 | 929 | 1,000 |
| Total Liabilities | 908 | 1,528 | 1,905 | 1,343 | 1,388 | 1,463 | 1,393 | 1,451 | 1,529 | 1,540 | 1,602 |
| Current Liabilities | 406 | 290 | 664 | 431 | 434 | 495 | 460 | 512 | 559 | 627 | 505 |
| Non Current Liabilities | 264 | 290 | 247 | 227 | 207 | 236 | 156 | 199 | 221 | 200 | 327 |
| Total Equity | 238 | 948 | 994 | 685 | 747 | 732 | 776 | 740 | 749 | 713 | 770 |
| Reserve & Surplus | 32 | 885 | 928 | 599 | 657 | 637 | 678 | 633 | 649 | 607 | 654 |
| Share Capital | 31 | 48 | 49 | 49 | 49 | 50 | 50 | 50 | 50 | 50 | 50 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | -2 | 24 | -5 | 28 | 0 | -14 | 4 | -16 | 23 | -2 |
| Investing Activities | -157 | -311 | -116 | 7 | -68 | -72 | 10 | -94 | -65 | -6 | -25 |
| Operating Activities | -24 | -0 | -7 | 45 | 116 | 115 | 115 | 31 | 17 | 31 | 83 |
| Financing Activities | 179 | 309 | 147 | -57 | -20 | -43 | -139 | 67 | 32 | -1 | -61 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 53.86 % | 53.86 % | 53.52 % | 53.02 % | 53.02 % | 52.79 % | 52.79 % | 52.79 % | 52.79 % | 52.79 % | 52.79 % | 52.79 % | 52.79 % | 52.78 % | 52.76 % | 52.61 % | 52.61 % | 52.61 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 6.03 % | 0.00 % | 6.16 % | 5.70 % | 6.45 % | 6.10 % | 6.05 % | 6.15 % |
| DIIs | 2.68 % | 2.11 % | 1.49 % | 0.51 % | 0.30 % | 0.29 % | 1.66 % | 2.81 % | 2.92 % | 2.92 % | 3.23 % | 5.02 % | 7.59 % | 8.06 % | 9.99 % | 12.02 % | 12.82 % | 12.98 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 19.28 % | 19.04 % | 19.57 % | 26.31 % | 27.64 % | 28.20 % | 27.92 % | 28.61 % | 29.03 % | 28.85 % | 29.25 % | 25.11 % | 24.43 % | 25.01 % | 24.00 % | 23.82 % | 23.43 % | 22.37 % |
| Others | 24.19 % | 25.00 % | 25.42 % | 20.17 % | 19.04 % | 18.72 % | 17.63 % | 15.80 % | 15.26 % | 15.44 % | 8.70 % | 17.08 % | 9.02 % | 8.45 % | 6.80 % | 5.46 % | 5.09 % | 5.89 % |
| No of Share Holders | 0 | 62,318 | 86,848 | 1,24,014 | 1,67,812 | 1,91,092 | 1,97,176 | 1,93,954 | 1,96,231 | 1,87,474 | 1,84,521 | 1,72,853 | 1,66,593 | 1,63,693 | 1,54,603 | 1,62,574 | 1,58,152 | 1,47,320 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.2 | 0.2 | 0.00 | 0.5 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.28 | 0.26 | 0.00 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Aug 2025 |  Annual General Meeting | NA | 08 Aug 2025 | 181.65 | 173.85 |
| 20 May 2025 |  Quarterly Result Announcement | NA | 20 May 2025 | 153.25 | 177.30 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 160.00 | 156.65 |
| 13 Nov 2024 | Quarterly Result Announcement | NA | 13 Nov 2024 | 211.07 | 202.90 |
| 17 Sept 2024 | Annual General Meeting | NA | 17 Sept 2024 | 165.50 | 178.10 |
| 10 Sept 2021 |  Dividend | ₹ 0.50 /share | 08 Sept 2021 | 322.30 | 236.15 |
Announcements
Disclosure Under Regulations 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).3 hours ago
3 hours agoAnnouncement Under Regulation 30 -Update10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationJul 17, 2025
Jul 17, 2025Letter To The Shareholders - Annual Report F.Y. 2024-25Jul 16, 2025
Jul 16, 2025Reg. 34 (1) Annual Report.Jul 16, 2025
Jul 16, 2025Business Responsibility and Sustainability Reporting (BRSR)Jul 16, 2025
Jul 16, 2025Notice Of 40Th Annual General Meeting Scheduled On August 08 2025.Jul 16, 2025
Jul 16, 2025Reg. 34 (1) Annual Report.Jul 16, 2025
Jul 16, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2025
Jul 16, 2025Re-Appointment Of Non-Executive Independent Directors.Jul 14, 2025
Jul 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Jul 08, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 26, 2025
Jun 26, 2025Closure of Trading WindowJun 25, 2025
Jun 25, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 18, 2025
Jun 18, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 29, 2025
May 29, 2025Receipt Of Observation Letters With No Adverse Observations From BSE Limited And No Objection From The National Stock Exchange Of India Limited On The Composite Scheme Of
AmalgamationMay 26, 2025
May 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 20, 2025
May 20, 2025Announcements Under Reg 30May 20, 2025
May 20, 2025Appointment Of M/S BMP & Co. LLP As Secretarial AuditorMay 20, 2025
May 20, 2025ResultsMay 20, 2025
May 20, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated 20 May 2025May 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2025
May 13, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 08, 2025
May 08, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Apr 30, 2025
Apr 30, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 24, 2025
Apr 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Apr 08, 2025Registered Office Of The Company Has Been Shifted From Maharashtra To TelanganaApr 01, 2025
Apr 01, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 (Listing Regulations)Mar 11, 2025
Mar 11, 2025Update - Shifting Of Registered OfficeMar 11, 2025
Mar 11, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 20, 2025
Feb 20, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 17, 2025
Feb 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 13, 2025
Feb 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2025
Feb 12, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 11, 2025
Feb 11, 2025Integrated Filing (Financial)Feb 11, 2025
Feb 11, 2025Outcome Of Board Meeting Held On February 11 2025 Along With Unaudited Standalone And
Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 11, 2025
Feb 11, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On February 11 2025 Along With Unaudited Standalone And
Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 11, 2025
Feb 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2025
Feb 06, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 04, 2025
Feb 04, 2025Intimation Under Regulation 30 Of The Securities Exchange Board Of India (Listing
Obligations And Disclosure Requirements) Regulations 2015Feb 01, 2025
Feb 01, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementJan 22, 2025
Jan 22, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 21, 2025
Jan 21, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 20, 2025
Jan 20, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Jan 10, 2025Technical Indicators
RSI(14)
Neutral 39.14
ATR(14)
Less Volatile 7.06
STOCH(9,6)
Neutral 30.14
STOCH RSI(14)
Oversold 9.04
MACD(12,26)
Bearish -1.40
ADX(14)
Weak Trend 16.04
UO(9)
Bearish 33.16
ROC(12)
Downtrend But Slowing Down -5.31
WillR(14)
Oversold -88.08
Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth | 0.29% | 10747 | -0.01% | 0.04% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.17% | 29 | -0.01% | 0.04% | |
 Groww Nifty Total Market Index Fund Direct - Growth | 0.01% | 25 | 0.00% | 0.00% | |
 Angel One Nifty Total Market Index Fund Direct - Growth | 0.01% | 19 | 0.00% | 0.00% | |
| Bandhan Nifty Total Market Index Fund Direct-Growth | 0.01% | -5 | 0.00% | 0.00% | |
 Mirae Asset Nifty Total Market Index Fund Direct-Growth | 0.01% | 2 | 0.00% | 0.00% | |
 ITI Pharma and Healthcare Fund Direct - Growth | 0.00% | 0 | 0.00% | -0.98% | |
| ITI ELSS Tax Saver Fund Direct - Growth | 0.00% | 0 | 0.00% | -1.07% | |
 Quant Healthcare Fund Direct - Growth | 6.69% | 0 | -0.10% | 1.79% | |
| Quant Small Cap Fund Direct Plan-Growth | 1.46% | 0 | -0.07% | 0.23% | |
 Samco Multi Cap Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 UTI Healthcare Fund Direct-Growth | 1.53% | 0 | -0.05% | 0.02% | |
 WhiteOak Capital Pharma and Healthcare Fund Direct - Growth | 0.00% | 0 | 0.00% | 0.00% |
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
